|
 |
Biaxin XLThis page contains recent news articles, when available, and an overview of Biaxin XL but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Biaxin XL (when available) Clarithromycin, a macrolide antibiotic similar to erythromycin and azithromycin, is effective against Mycobacterium avium complex (MAC) and is used for the treatment of Helicobacter pylori-associated peptic ulcer disease, community-acquired pneumonia, sinusitis, and chronic bronchitis. Clarithromycin is also used to treat respiratory tract, sexually transmitted, otitis media, and AIDS-related infections. For the treatment of Bacterial infection of (Pharyngitis/Tonsillitis, sinusitis, bronchitis, Pneumonia, Uncomplicated skin and skin structure infections ) caused by H.influenzae, M.catarrhalis, M.pneumoniae, S.pneumoniae, C.pneumoniae (TWAR), S.aureus, S Mechanism Of Action: Clarithromycin is first metabolized to 14-OH clarithromycin. Like other macrolides, it then binds to the 50 S subunit of the 70 S ribosome of the bacteria, blocking RNA-mediated bacterial protein synthesis. Clarithromycin also inhibits the hepatic microsomal CYP3A4 isoenzyme and P-glycoprotein, an energy-dependent drug efflux pump. News Articles on Clarithromycin Article: Bright Abbott outlook called 'aggressive' - Chicago Sun... - Dec 16, 2005 Full prescribing information for Biaxin XL and Biaxin available upon . ... InvestSource Inc.: Abbott Laboratories gets new patent for Biaxin XL: ESSE, IPCY, ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Watson launches generic Biaxin XL drug - Jan 3, 2008 By : Agencies. CORONA, Calif. (AP) - Specialty pharmaceutical company Watson Pharmaceuticals Inc. launched a generic tablet Thursday aimed at treating or ... ABCmoney.co.uk Abbott Biaxin ruling reversed in appeal court: Judges say Israeli... - Jun 23, 2006 If Teva starts selling its Biaxin XL version and ultimately loses the patent case, ... The new once- a-day tablets will be sold as Biaxin XL and should be ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Abbott wins ruling on generic Biaxin sale ; Appeals court halts rival... - Jan 6, 2007 Biaxin XL is the extended-release version of the antibiotic. The regular form of the drug already has generic competition. Last month, North Chicago-based ... Pay-Per-View - Chicago Tribune - ProQuest Archiver … (TEVA) Issues Press Release Regarding Generic Biaxin XL - Jun 22, 2006 Northern District of Illinois, which had granted Abbott's (NYSE: ABT) motion for a preliminary injunction related to Teva's generic Biaxin XL Filmtabs. ... StreetInsider.com - StreetInsider.com (subscription) Abbott Wins Preliminary Injunction Against Andrx, Ranbaxy for Biaxin... - Nov 14, 2005 Abbott's Biaxin XL (clarithromycin) is an antibiotic indicated for the ... Biaxin XL accounted for roughly two-thirds of the $458 million in total US Biaxin ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones Abbott fails to block copy of antibiotic - Dec 19, 2006 Sandoz began selling generic Biaxin XL on Dec. 4, Weinstein said. Abbott claims that the Sandoz version infringes three patents, including one for an ... Pay-Per-View - Chicago Tribune - ProQuest Archiver First-Time Generic Approvals: Terazol 7, DDAVP Nasal Spray, Biaxin... - Feb 18, 2005 The 1-g generic formulation is considered to be equivalent to two 500-mg tablets of the brand-name formulation (Biaxin XL Filmtab, made by Abbott ... Medscape ABBOTT LABORATORIES: Reaches settlement over Biaxin lawsuit - Aug 2, 2006 ..."Abbott has reached an agreement in principle to settle our outstanding litigation regarding Biaxin XL with Teva," Abbott spokesman Jonathon Hamilton said. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Abbott Laboratories gets new patent for Biaxin XL: ESSE, IPCY, ABT. - Mar 30, 2005 Earth Search Sciences, Incorporated (OTC: ESSE) is engaged in exploiting the science of remote sensing in a wide variety of industries worldwide. ... Free with registration - M2 Presswire - AccessMyLibrary.com J&J, Nike, Capcom, Google: Intellectual Property - Oct 22, 2008 Biaxin XL, the extended-release version of the antibiotic, is taken once a day. The regular version, taken twice a day, also has generic competition. ... Bloomberg Press Release: Advanced Life Sciences Announces Supplemental … - Jul 2, 2007 Biaxin XL is the once-daily ... demonstrates that the clinical cure rate achieved with Biaxin XL ... Biaxin XL is now available in pharmacies nationwide ... ... Pay-Per-View - PR Newswire - HighBeam Research … : Abbott Laboratories gets new patent for Biaxin XL: ESSE, IPCY,... - Mar 30, 2005 Abbott Laboratories gets new patent for Biaxin XL: ESSE, IPCY, ABT. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Ranbaxy Receives Final Approval for Clarithromycin XL 1000 Mg Tablet - Feb 1, 2005 For the same period, Biaxin XL (Clarithromycin XL 500 mg tablets) accounted for approximately 60 percent of that market, with $320.5 million in sales. ... RedOrbit Press Release: Cethromycin Achieves Primary Endpoint in Pivotal Phase... - Jun 21, 2007 Biaxin XL is now available in pharmacies nationwide ... ... Sales of Biaxin XL(R) were approximately $300 million in the past twelve ... ... Pay-Per-View - PR Newswire - HighBeam Research Abbott Laboratories v. Sandoz, Inc., No. 05 C 5373 (NDIll. 12/15/2006) - Dec 15, 2006 Abbott began marketing this extended release formulation under the name BIAXIN XL in 2000. As of May 2005, Abbott estimated that BIAXIN XL accounted for ... $2.95 - U.S. District Court, Northern District... - VersusLaw … court grants Abbott's request for preliminary injunction against... - Dec 21, 2005 Biaxin XL is indicated for respiratory tract infections. Abbott is a broad-based healthcare company discovering, developing, manufacturing and marketing ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Abbott Revenue Jumps 16% - Apr 12, 2005 Biaxin XL, the extended release form of its clarithromycin antibiotic drug, now makes up 70% of Biaxin sales. The remainder comes from its immediate release ... TheStreet.com - TheStreet.com (subscription) Teva Shareholders Feeling Ill - Jun 6, 2005 Teva, which is based in Israel, says Abbott's patent for Biaxin XL Filmtabs is invalid, and the company intends to seek an expedited appeal. ... TheStreet.com - TheStreet.com (subscription) Press Release: Advanced Life Sciences Announces Cethromycin … - Jun 21, 2007 Abbott Laboratories gets new patent for Biaxin XL: ESSE, IPCY, ABT(C)1994-2005 ... Tuesday said it received a new patent for Biaxin XL, the extended-release ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Ranbaxy Receives Final Approval for Clarithromycin XL ... - Feb 1, 2005 For the same period, Biaxin XL (Clarithromycin XL 500 mg tablets) accounted for ... Biaxin XL Filmtab(R) is a registered trademark of Abbott Laboratories ... Pay-Per-View - PR Newswire - HighBeam Research Report muscle problems while on statin drugs - Apr 12, 2006 Q. An ENT doctor prescribed an antibiotic called Biaxin XL. After the fifth dose, I developed severe muscle problems in my shoulders and upper arms as well ... Pay-Per-View - St. Paul Pioneer Press - Factiva, from Dow Jones Abbott Revenue Jumps 16% - Apr 7, 2005 Biaxin XL, the extended release form of its clarithromycin antibiotic drug, now makes up 70% of Biaxin sales. The remainder comes from its immediate release ... TheStreet.com - TheStreet.com (subscription) Loislaw Federal District Court Opinions - ABBOTT LABORATORIES v. … - Apr 16, 2007 ABBOTT LABORATORIES v. SANDOZ, INC. (N.D.Ill. 2007). 500 F. Supp.2d 807. ABBOTT LABORATORIES, Plaintiff, v. SANDOZ, INC., Defendant. No. 05 C 5373. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Abbott Laboratories v. Andrx Pharmaceuticals, Inc., 452 F.3d 1331, 79... - Jun 22, 2006 In 2000, Abbott introduced its ER clarithromycin formulation, Biaxin XL. As of May 2005, Abbott estimated that, as between Biaxin and Biaxin XL, Biaxin XL ... $2.95 - U.S. Court of Appeals, Federal Circuit - VersusLaw Abbott Shares At 'Compelling Entry Point' - Sep 20, 2005 ..."Abbott's next challenge seems to be generic Biaxin XL litigation, which continues tomorrow in a Preliminary Injunction (PI) hearing between Abbott and ... Forbes Watson Pharmaceuticals. - Feb 11, 2008 For the 12 months ended September 2007, Biaxin XL and its generic equivalents had total U.S. sales of approximately $200 million, according to IMS Health ... $9.94 - Drug Store News - Alacra Store Ranbaxy gets FDA nod for Clarithromycin - Feb 3, 2005 The formulation will have the same therapeutic effect as Biaxin XL Filmtab Extended Release tablets 500 mg of Abbott Laboratories. ... Hindu Business Line Andrx "neutral" - Mar 20, 2006 The market had expected Andrx's Biaxin XL generic to have a monopoly of the market, the analyst says. According to First Albany, channel checks indicate ... newratings.com Event Brief of Q1 2007 Abbott Laboratories Earnings Conference Call -... - Apr 18, 2007 Generic competition for Biaxin XL in 1Q07 and nonrecurring BI revenue in 1Q06. 3. ... lower US Biaxin XL sales as previously forecasted. 4. R&D and SG&A: 1. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Report any muscle problems while on statin drugs. - Mar 24, 2006 Q: An ENT doctor prescribed an antibiotic called Biaxin XL. After the fifth dose I developed severe muscle problems in my shoulders and upper arms as well ... Free with registration - Sun Herald - AccessMyLibrary.com Q4 2006 Abbott Laboratories Earnings Conference Call - Part 2. - Jan 2, 2007 Regarding Biaxin XL, we saw an at-risk generic launch at the end of last ... We also expect very modest levels of Biaxin XL sales in the US going forward. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Generic Drugs; Pharma company receives final approval for … - Feb 28, 2005 For the same period, Biaxin XL (Clarithromycin XL 500 mg tablets) accounted for approximately 60% of that market, with $320.5 million in sales. ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Federal Circuit Affirms Abbott's Biaxin Injunction. - Feb 1, 2007 The Court commenced its analysis by rejecting Andrx's claim that Abbott was precluded from asserting certain claims in the three Biaxin XL-related patents ... Free with registration - Mondaq Business Briefing - AccessMyLibrary.com United States Federal Circuit Court of Appeals Reports - ABBOTT LAB.... - Jun 22, 2006 In 2000, Abbott introduced its ER clarithromycin formulation, Biaxin XL. As of May 2005, Abbott estimated that, as between Biaxin and Biaxin XL, Biaxin XL ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Press Release: New Study Supports Use of LEVAQUIN as a Guideline- … - Oct 27, 2008 Biaxin XL is the ... levofloxacin), in the treatment of CAP. ... Article: Abbott Laboratories Submits Supplemental NDA For Biaxin XL(R) ... ... Pay-Per-View - PR Newswire - HighBeam Research United States: Federal Circuit Affirms Abbott´s Biaxin Injunction - Jan 2, 2007 The Court commenced its analysis by rejecting Andrx's claim that Abbott was precluded from asserting certain claims in the three Biaxin XL-related patents ... Mondaq News Alerts - Mondaq News Alerts (Registration) Ranbaxy Inc. Pharma company receives final approval for Clarithromycin... - Mar 2, 2005 For the same period, Biaxin XL (Clarithromycin XL 500 mg tablets) accounted for approximately 60% of that market, with $320.5 million in sales. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Bright Abbott outlook called 'aggressive' - Dec 16, 2005 ...and prostate cancer drug Xinlay reach the market and that antibiotics Omnicef and Biaxin XL remain largely unscathed from potential generic competition. ... $2.95 - Chicago Sun-Times - NewsBank Patent extenders stretch drugmakers' bottom lines. - Sep 10, 2006 Biaxin known as clarithromycin came on the market last year, the twice-a-day copy has eaten into once-a-day Biaxin XL, which was introduced in 2000. ... Free with registration - Chicago Tribune - AccessMyLibrary.com United States Federal Circuit Court of Appeals Reports - ABBOTT LABS.... - Jan 5, 2007 Each of these defendants sought approval to manufacture and market a generic version of Biaxin XL® and accordingly filed abbreviated new drug applications ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Loislaw Federal District Court Opinions - ABBOTT LABORATORIES v. … - Jun 3, 2005 Abbott began marketing this extended release formulation under the name BIAXIN XL in 2000. As of May 2005, Abbott estimated that BIAXIN XL accounted for ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Analyst fears generics could cut into Abbott profits - Mar 28, 2005 The company markets two formulations of the drug--Biaxin and Biaxin XL, ... Abbott has said two-thirds of Biaxin users have switched to Biaxin XL, ... $2.95 - Chicago Sun-Times - NewsBank Loislaw Federal District Court Opinions - ABBOTT LABORATORIES v. … - May 20, 2005 Abbott contends that although it did not invent the concept of extended release formulations, it did successfully determine how to formulate Biaxin XL such ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Loislaw Federal District Court Opinions - RANBAXY LABORATORIES … - Nov 10, 2005 6872407 ("the '407 patent"), relating to its BIAXIN XL product. ... As of May 2005, Abbott estimated that BIAXIN XL accounted for approximately 70% of the ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Southern Illinoisan : News<br> - Mar 28, 2006 Question: An ENT doctor prescribed an antibiotic called Biaxin XL. After the fifth dose I developed severe muscle problems in my shoulders and upper arms as ... $2.95 - Southern Illinoisan - NewsBank Press Release: Watson Launches Generic Biaxin(R) XL. - PR Newswire | ... - Jan 3, 2008 Article: Abbott Laboratories Submits Supplemental NDA For Biaxin XL(R) ... PR Newswire; October 25, 2000 ; 700+ words ... ... Food and Drug Administration ... Pay-Per-View - PR Newswire - HighBeam Research Zacks Brokerage Buy List: Abbot Labs, Automatic Data Processing,... - Apr 1, 2005 Earlier this week, the company said that the US Patent and Trademark Office issued a new patent for BIAXIN XL, which delays rivals from developing a generic ... $4.95 - Business Wire - ECNext Event Brief of Q1 2005 Abbott Laboratories Earnings Conference Call -... - Apr 12, 2005 Patent and Trademark office issued a new patent on Biaxin XL, its extended-release once daily version of Biaxin. 1. The new patent, which is supported by ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Abbott Moves to Block Biaxin Sales - Jun 27, 2006 ...said Tuesday that Abbott Laboratories filed an emergency motion to stop Teva from further sales of its generic Biaxin XL Filmtabs. ... TheStreet.com - TheStreet.com (subscription) Generic makers see opportunity in '08 expirations.(Generics) - Feb 11, 2008 The company already has launched a generic of the antibiotic Biaxin XL and has just released a generic of the multibillion dollar drug Fosamax. ... Free with registration - Drug Store News - AccessMyLibrary.com IN BRIEF; Also - Jan 6, 2007 Abbott Laboratories won an appeals court ruling stopping Andrx Pharmaceuticals Inc. from selling generic versions of the antibiotic Biaxin XL until a patent ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Teva Shares Could Rise 15%-20% In 12 Months - Aug 2, 2005 ...results--which was not overly surprising given the near-term challenges and pre-announcement surrounding the generic Biaxin XL delay," said SG Cowen. ... Forbes Orange County Business Journal Online - Jan 28, 2008 Watson's clarithromycin extended-release tablets are a generic version of Biaxin XL, which was developed by Abbott Laboratories Inc. of suburban Chicago. ... Orange County Business Journal - Orange County Business Journal Prickly Prognosis at Battered Andrx - Sep 6, 2005 Andrx remains engaged in a patent lawsuit with Abbott (ABT - commentary - Cramer's Take) over that company's Biaxin XL antibiotic. ... TheStreet.com - TheStreet.com (subscription) S&P Keeps Buy on AIG - Apr 12, 2005 Assumptions include successful defense of Biaxin XL from generics. Our 12-month discounted-cash-flow-based target price remains $54. ... BusinessWeek Safety Issues Dominate Health News - Apr 4, 2005 ...after the biotech firm said on Tuesday that it received new patent protection for its antibiotic Biaxin XL. Shares gained 1.26% in Tuesday's session. ... Forbes Abbott Labs Still Has 'Considerable' Upside Potential - Nov 28, 2005 Positive events for Abbott in 2005 included defending the Biaxin XL franchise against generic competition, gaining access to rapid exchange stent delivery ... Forbes Abbott Labs' Products Could See Sales Upside - Aug 17, 2005 Near-term potential catalysts include the Andrx (nasdaq: ADRX - news - people ) hearing over Biaxin XL in early September and the ODAC panel on Xinlay." ... Forbes Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY … - Feb 19, 2007 5.2 158 Inderal LA 175218 -1.4 159 Prilosec 174624 -5.1 160 Catapres-TTS 174137 6.8 161 NuvaRing 173168 55.0 162 Biaxin XL 171873 -32.6 163 Zyrtec Syrup ... Free with registration - Drug Topics - AccessMyLibrary.com LPHI, MBRK, MKTAY, NURO, NVEC, VEXP Have Also Been Added To … - Feb 5, 2008 It has a collaboration agreement with Par Pharmaceutical for the distribution and marketing of the company's generic formulation of Abbott's Biaxin XL ... Free with registration - M2 Presswire - AccessMyLibrary.com Earnings decline at Andrx for Q4, year - Mar 17, 2006 ...recent quarter included a $5.6 million charge on inventory because Andrx has not yet been able to launch its regulator-approved generic for Biaxin XL. ... Bizjournals.com RealPennies.com: Turning Pennies into dollars: (NASDAQ: WRLD), ( … - Jan 28, 2008 It has a collaboration agreement with Par Pharmaceutical for the distribution and marketing of the company's generic formulation of Abbott's Biaxin XL ... Free with registration - M2 Presswire - AccessMyLibrary.com סיכוי להפתעה חיובית לטבע ×¢×? biaxin - Apr 19, 2007 ...טבע × ×•×ª×¨×” כרגע החברה היחידה הפעילה בשוק ×”×’× ×¨×™ של מוצר ×”-Biaxin XL וז×?ת ל×?חר שביהמ"ש ×?ישר ×?ת ... Bizportal Competitors by Product Report - Mar 29, 2008 Biaxin (Clarithromycin); Biaxin XL (Clarithromycin); E.E.S. (Erythromycin Ethylsuccinate); Ery-Tab (Erythromycin Delayed-ReleaseTabkets) ... $75.00 - Revere Reports - Revere Top 200 brand-name drugs by units in 2005.(rankings ) - Mar 20, 2006 Humulin N 3190 -15.9 102 Budeprion SR 3137 25.4 103 Kariva 3128 -0.9 104 Abilify 3050 37.5 105 Biaxin XL 3036 1.6 106 Lunesta 2981 .999 107 Prempro 2953 ... Free with registration - Drug Topics - AccessMyLibrary.com Abbott wins new round of approval for Humira - Oct 5, 2005 ...that was below analysts' expectations, FDA rejection of its prostate cancer drug Xinlay and potential generic risk facing its antibiotic Biaxin XL. ... $2.95 - Chicago Sun-Times - NewsBank Article: Biz Briefs - Chicago Sun-Times | HighBeam Research - FREE... - Jan 6, 2007 Abbott Laboratories won an appeals court ruling Friday stopping Andrx Pharmaceuticals Inc. from selling generic versions of the antibiotic Biaxin XL until a ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Event Brief of Q4 2004 Andrx Corporation Earnings Conference Call - … - Mar 10, 2005 ADRX received final approval on generic Biaxin XL Filmtab 500mg for which the Co. is continuing to evaluate its launch plans after the expiration of the May ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Abbott Laboratories at Morgan Stanley Healthcare Conference - Final. - May 4, 2005 Clearly the way we review Biaxin XL and the path that's made around it in particular the PK patent that just came out at the end of March. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Top 200 brand name drugs by units in 2006.(COMMUNITY PRACTICE)( … - Mar 5, 2007 ...-8.9 140 Ortho Tri-Cyclen 1989 -47.7 141 Prometrium 1971 -5.0 142 Geodon Oral 1960 20.2 143 Glipizide XL 1953 28.2 144 Biaxin XL 1944 -36.0 145 Micardis ... $4.95 - Drug Topics - ECNext Abbott wins new round of approval for Humira | Article from Chicago... - Oct 5, 2005 ...that was below analysts' expectations, FDA rejection of its prostate cancer drug Xinlay and potential generic risk facing its antibiotic Biaxin XL. ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Teva drops 8% on forecast cut | Article from Jerusalem Post |... - Jun 6, 2005 The medication is a generic equivalent of Abbott's antibiotic Biaxin XL Filmtabs. "Investors were surprised by the announcement," said Ysca Erez, ... Pay-Per-View - Jerusalem Post - HighBeam Research [ BIZ BRIEFS ] | Article from Chicago Sun-Times | HighBeam Research - Mar 30, 2005 Abbott Laboratories received new patent protection for its antibiotic Biaxin XL, which has faced generic challenges. The North Chicago-based company said in ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Watson Pharmaceuticals, Inc./ Andrx Corporation Merger & … - Mar 13, 2006 Its pipeline product, including generic Toprol-XL, Cardizem LA, Prilosec, generic Concerta and generic Biaxin XL Filmtab. ANDA, the Andrx distribution ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Global top 200 brand-name drugs ranked by retail sales in dollars and... - Feb 21, 2005 Patanol 257327 4.8 104 Coumadin Tabs 253341 -10.2 105 Zelnorm 251846 89.4 106 Ortho Tri-Cyclen Lo 247173 160.8 107 Biaxin XL 244968 -16.2 108 Glucovance ... $20.00 - Drug Topics - Alacra Store Acquisitive Takeda snaps up biotech Millennium.(NEWS) | Article from ... - May 1, 2008 Abbott Laboratories received FDA approval to market a once-daily formulation of Biaxin XL (clarithromycin) extended-release tablets. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research United States top 200 brand-name pharmaceuticals by retail sales in … - Feb 19, 2007 5.2 158 Inderal LA 175218 -1.4 159 Prilosec 174624 -5.1 160 Catapres-TTS 174137 6.8 161 NuvaRing 173168 55.0 162 Biaxin XL 171873 -32.6 163 Zyrtec Syrup ... $20.00 - Drug Topics - Alacra Store United States top 200 brand-name drugs by retail sales in dollars and... - Mar 6, 2006 119 Amaryl 262732 -5.5 120 Avandamet 261746 -20.7 121 AndroGel 260799 7.4 122 Avelox 259386 10.2 123 Neurontin 255121 -87.2 124 Biaxin XL 255017 4.1 125 ... $20.00 - Drug Topics - Alacra Store Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY … - Feb 19, 2007 5.2 158 Inderal LA 175218 -1.4 159 Prilosec 174624 -5.1 160 Catapres-TTS 174137 6.8 161 NuvaRing 173168 55.0 162 Biaxin XL 171873 -32.6 163 Zyrtec Syrup ... $4.95 - Drug Topics - ECNext Andrx Fights to Undo Several Years of Damage - Sep 26, 2005 Andrx has some other big generics in the pipeline, including the already delayed antibiotic Biaxin XL, as well as copies of blood pressure drugs Cardizem LA ... RedOrbit Q4 2004 Andrx Corporation Earnings Conference Call - Final. - Mar 10, 2005 We also received final approval on generic Biaxin XL (indiscernible) 500 mg for which we are continuing to evaluate our launch plans after the expiration of ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com New generics.(product introduction, drug approvals) - Mar 7, 2005 The 1000-mg tablet offers a single-dose tablet as an equivalent dosage to two of Abbott Laboratories' Biaxin XL Filmtab Extended Release 500-mg tablets once ... Free with registration - Drug Topics - AccessMyLibrary.com Andrx Corporation Reports 2005 Second Quarter Results - Jun 30, 2005 Inc. entered into an agreed temporary restraining order (TRO) to enjoin us from selling or offering to sell our generic version of Biaxin XL in the ... businesswire.com Fitch Downgrades Watson's Ratings to 'BBB-'. - Nov 6, 2006 ...most notably generic versions of Toprol XL, 50mg; Biaxin XL; Concerta; Cardizem LA; Lovenox (with Amphastar); and Prilosec delayed-release. ... Free with registration - Business Wire - AccessMyLibrary.com United States Federal Circuit Court of Appeals Reports - ABBOTT … - Oct 21, 2008 ABBOTT LABORATORIES v. SANDOZ, INC., 544 F.3d 1341 (Fed. Cir. 2008). ABBOTT LABORATORIES, Plaintiff-Appellee, v. SANDOZ, INC.,. Defendant-Appellant. ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Factiva Search - Mar 27, 2006 Q: An ENT doctor prescribed an antibiotic called Biaxin XL. After the fifth dose I developed severe muscle problems ... (c) Copyright 2006, Contra Costa ... Pay-Per-View - Contra Costa Times - Factiva, from Dow Jones Press Release: US District Court Grants Abbott's Request for a … - Nov 11, 2005 Chicago today granted Abbott's request for a preliminary injunction that will prevent unauthorized generic copies of Abbott's Biaxin XL from Ranbaxy and ... Pay-Per-View - PR Newswire - HighBeam Research Q2 2007 Abbott Laboratories Earnings Conference Call - Final. - Jul 18, 2007 ...as well as the impact of generic competition on Omnicef and Biaxin XL sales. On the basis we originally forecasted the quarter, which excluded core ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com US District Court Grants Abbott's Request for a Preliminary Injunction... - Nov 11, 2005 Chicago today granted Abbott's request for a preliminary injunction that will prevent unauthorized generic copies of Abbott's Biaxin XL from Ranbaxy and ... $4.95 - PR Newswire - ECNext Event Brief of Q4 2005 Andrx Corporation Earnings Conference Call - … - Mar 17, 2006 ...including $5.6m in charges related to the generic version of Biaxin XL due to the aging of the product that may be short-dated by the date ADRX ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com United States: Combination of Prior Art Defeats Showing of Likelihood... - Jul 24, 2006 In a post-eBay case that echoes the recent Supreme Court decision, the US Court of Appeals for the Federal Circuit applied the "four-factor" test and ... Mondaq News Alerts - Mondaq News Alerts (Registration) Zacks Broker Upgrades: Deere & Co., Dell, Abbott, Network Appliance … - Nov 30, 2006 Most analysts are concerned about the generic threat to Biaxin/Biaxin XL. One firm believes that 2007 will be a difficult year for ABT as several drugs are ... RedOrbit Andrx put on hold following FDA action - Sep 12, 2005 He trimmed his 2005 revenue forecast from $343 million to $321 million, noting that FDA action also makes uncertain the launch of generic Biaxin XL, ... ICIS Q3 2005 Andrx Corporation Earnings Conference Call - Part 1. - Nov 8, 2005 On September 21 a preliminary injunction hearing took place regarding our generic version of Biaxin XL which was approved by FDA in June, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Euro RSCG life: overcame a year of challenges and uncertainty with … - Jul 1, 2006 MetaMax picked up the professional advertising business for Abbott's Biaxin XL, Novartis' Benefiber and Endo's Synera, which the shop launched last month, ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com BUSINESS BRIEFS.(TO THE POINT) - Mar 30, 2005 The drug and medical products maker received a new patent for Biaxin XL, a form of an antibiotic that treats bacterial respiratory tract infections. ... Free with registration - Investor's Business Daily - AccessMyLibrary.com Collateral Estoppel Does Not Extend to Preliminary Injunction Findings - Jan 17, 2007 The district court granted a preliminary injunction to stop Andrx from selling extended release clarithomycin as a generic version of Biaxin XL. ... Patently-O Teva Allowed To Market Generic Abbot Labs Antibiotic. - Jun 23, 2006 ...generic version of Abbot Laboratories (NYSE: ABT) Biaxin XL Filmtabs after a federal appeals court overruled a lower court decision that would have kept ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com FDA pipeline.(Food and Drug Administration)(drug approvals) - Apr 1, 2005 Clarithromycin extended-release tablets 1000 mg (equiv to Biaxin XL extended-release tablets 500 mg)--RANBAXY * Levofloxacin tablets 750 mg (equiv to ... Free with registration - Managed Healthcare Executive - AccessMyLibrary.com Brand Names/Synonyms: Biaxin XL is also known by the following brand names and/or synonymsBiaxin; Biaxin Xl; CAM; CLA; Clarithromycin; Clarithromycine; Clathromycin; Klacid; Klaricid; Macladin; Naxy; Prevpac; Veclam; Zeclar Drug Category: Biaxin XL is categorized under the following by the FDA: Anti-bacterial Agents; Other Macrolides; ATC:J01FA09 Dosage Forms: suspension and tablets Absorption: 50% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 6-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl)oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
